HI
ABBV icon

Harrington Investments’s AbbVie ABBV Stock Holding History

Harrington Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-425
Closed -$40K – 77
2018
Q3 		$40K Buy
425
+150
+55% +$14.2K 0.03% 104
2018
Q2 		$25K Hold
275
– – 0.02% 111
2018
Q1 		$26K Buy
+275
New +$30.2K 0.02% 110

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harrington Investments's ABBV Position: Q4 2018 in Review

Harrington Investments sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 425 shares — an estimated $40K sold.

Harrington Investments first reported a position in ABBV in Q1 2018 and held it in 3 quarters. The position peaked at $40K in Q3 2018. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Harrington Investments reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Harrington Investments sold 425 AbbVie shares in Q4 2018, an estimated $40K.
  • Harrington Investments first reported a position in AbbVie in Q1 2018 and held it in 3 quarters.
  • Harrington Investments's AbbVie position peaked at $40K in Q3 2018.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Harrington Investments's 13F filing for Q4 2018, filed 1 Feb 2019.